Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.80
Bid: 104.80
Ask: 105.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.191%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 104.80
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Aug 2023 12:29

RNS Number : 2547J
Hipgnosis Songs Fund Limited
14 August 2023
 

LEI: 213800XJIPNDVKXMOC11

14 August 2023

 

Hipgnosis Songs Fund Limited

("Hipgnosis" or the "Company")

 

Notification of Transactions of Persons Discharging Managerial Responsibilities (PDMRs)

The Company announces that it has been advised that Andrew Sutch, a Director of the Company, has acquired 1,071 ordinary shares in the Company ("Ordinary Shares") following the automatic reinvestment of dividend proceeds. Following this transaction, Mr Sutch holds a total of 65,996 Ordinary Shares, which equates to 0.005% of the issued share capital.

Details of the transaction can be found in the Notification of Dealing Form below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Andrew Sutch

 

2

Reason for the notification

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Hipgnosis Songs Fund Limited

b)

 

LEI

 

213800XJIPNDVKXMOC11

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

HIPGNOSIS SONGS FUND LIMITED, ORDINARY SHARES

 

 

GG00BFYT9H72

b)

 

Nature of the transaction

 

Reinvestment of dividend proceeds

c)

 

Price(s) and volume(s)

 

Price(s)79.5009 pence

Volume(s)

1,071

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

1,071

79.5009 pence

£851.45

e)

 

Date of the transaction

 

11 August 2023

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

For more information:

 

For further information please contact:

 

Hipgnosis Song Management

Merck Mercuriadis

Chris Helm

Giles Croot (Media)

Rufina Pavry (Investors)

 

 

 

 

 

+44 (0)20 4542 1511

+44 (0)20 4542 1530

Singer Capital Markets - Joint Corporate Broker

James Moat / James Maxwell / Alex Emslie (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

 

+44 (0)20 7496 3000

J.P. Morgan Cazenove - Joint Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

James Bouverat (Sales)

 

+44 (0)20 7742 4000

RBC Capital Markets - Joint Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

Lisa Tugwell / Natalia Lipecka (Sales)

 

+44 (0)20 7635 4000

Ocorian - Company Secretary & Administrator

Lorna Zimny

 

+44 (0) 28 9693 0222

The Outside Organisation

Alan Edwards / Nick Caley

 

+44 (0)7711 081 843

Headland Consultancy

Susanna Voyle / Del Jones / Charlie Twigg

 

+44 (0) 20 3805 4822

All US music publicity enquiries

Fran Defeo

 

+1 917 767 5255

 

Notes to Editors

About Hipgnosis Songs Fund

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of almost £1.3 billion (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019, October 2019, July 2020, September 2020, February 2021 and July 2021. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market, and in March 2020 became a constituent of the FTSE 250 Index. Since April 2021, the Company has been resident in the UK for tax purposes and is recognised as an investment trust under applicable HMRC regulations.

 

About Hipgnosis Song Management Limited

 

The Hipgnosis Songs Fund's Investment Adviser is Hipgnosis Song Management Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney Jerkins.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBGDIIDBDGXS
Date   Source Headline
14th Oct 20207:00 amRNSAdvisory Board Appointment & Catalogue Acquisition
2nd Oct 20203:34 pmRNSHolding(s) in Company
1st Oct 20204:11 pmRNSDirector/PDMR Shareholding
1st Oct 20207:00 amRNSTotal Voting Rights
24th Sep 20203:01 pmRNSResult of Equity Issue
21st Sep 20207:01 amRNSRetail Offer
21st Sep 20207:00 amRNSProposed Placing
17th Sep 20207:00 amRNSAppointment of Joint Broker
15th Sep 202010:16 amRNSHolding(s) in Company
14th Sep 20203:30 pmRNSHolding(s) in Company
11th Sep 20207:01 amRNSCapital Markets Day
11th Sep 20207:01 amRNSAcquisition of Music Catalogues
10th Sep 20207:00 amRNSAcquisition of Big Deal Music
9th Sep 20207:00 amRNSConversion of C Shares & Update to Dividend Target
8th Sep 20204:52 pmRNSResult of AGM
8th Sep 20207:00 amRNSAppointment of Ted Cockle and Amy Thomson
3rd Sep 20207:00 amRNSNotice of Capital Markets Day
1st Sep 20207:00 amRNSAcquisition of Music Catalogue
24th Aug 20207:00 amRNSAcquisition of Music Catalogue
13th Aug 20204:07 pmRNSDirector/PDMR Shareholding
13th Aug 20207:00 amRNSAcquisition of Music Catalogue
11th Aug 20204:44 pmRNSNotice of AGM
5th Aug 20207:00 amRNSAcquisition of Music Catalogue
3rd Aug 20207:00 amRNSTotal Voting Rights
3rd Aug 20207:00 amRNSAcquisition of Music Catalogue
29th Jul 20207:00 amRNSAcquisition of Music Catalogue
27th Jul 20203:05 pmRNSHolding(s) in Company
23rd Jul 20207:00 amRNSIncreased Debt Facility
21st Jul 20205:37 pmRNSHolding(s) in Company
20th Jul 20205:03 pmRNSHolding(s) in Company
20th Jul 20207:00 amRNSDirector/PDMR Shareholding
16th Jul 20204:17 pmRNSHolding(s) in Company
16th Jul 20207:00 amRNSAcquisition of Music Catalogue
15th Jul 20202:32 pmRNSHolding(s) in Company
14th Jul 20204:50 pmRNSPublication of Supplementary Prospectus
10th Jul 20203:51 pmRNSResult of C Share Issue
3rd Jul 20204:29 pmRNSFinal Results
3rd Jul 20207:01 amRNSDividend Declaration
2nd Jul 20207:01 amRNSPrimaryBid.com Offer
2nd Jul 20207:00 amRNSPlacing of C Shares & Date of Full Year Results
25th Jun 20206:17 pmRNSPublication of Supplmentary Prospectus
22nd Jun 20205:16 pmRNSHolding(s) in Company
12th Jun 202012:30 pmRNSDirector/PDMR Shareholding
12th Jun 20207:00 amRNSContemplation of Equity Raise & Result of EGM
4th Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSUnaudited NAV and Trading Update
29th May 20203:03 pmRNSProposed Amendment to Borrowing Policy
14th May 20207:01 amRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.